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Abstract
Background: Skeletal dysplasias are a rare and heterogeneous group of genetic disorders affecting skeletal
development. Patients with skeletal dysplasias suffer from many complex medical issues including degenerative
joint disease and neurological complications. Because the data and expertise associated with this field is both
sparse and disparate, significant benefits will potentially accrue from the availability of an ontology that provides a
shared conceptualisation of the domain knowledge and enables data integration, cross-referencing and advanced
reasoning across the relevant but distributed data sources.
Results: We introduce the design considerations and implementation details of the Bone Dysplasia Ontology. We
also describe the different components of the ontology, including a comprehensive and formal representation of
the skeletal dysplasia domain as well as the related genotypes and phenotypes. We then briefly describe
SKELETOME, a community-driven knowledge curation platform that is underpinned by the Bone Dysplasia
Ontology. SKELETOME enables domain experts to use, refine and extend and apply the ontology without any prior
ontology engineering experience–to advance the body of knowledge in the skeletal dysplasia field.
Conclusions: The Bone Dysplasia Ontology represents the most comprehensive structured knowledge source for
the skeletal dysplasias domain. It provides the means for integrating and annotating clinical and research data, not
only at the generic domain knowledge level, but also at the level of individual patient case studies. It enables links
between individual cases and publicly available genotype and phenotype resources based on a community-driven
curation process that ensures a shared conceptualisation of the domain knowledge and its continuous incremental
evolution.
Background
Skeletal dysplasias are a heterogeneous group of genetic
disorders affecting skeletal development. There are cur-
rently over 450 recognised types, clustered in 40 groups.
Patients with skeletal dysplasias have complex medical
issues including short stature, degenerative joint disease,
scoliosis and neurological complications. These patients
are also a precious resource for biomedical research as
they enable scientists to study the effects of single genes
on human bone and cartilage development and function.
The resulting insights lead to a better understanding of
the pathogenesis of more common connective tissue dis-
orders such as arthritis or osteoporosis.
Despite their importance, bone dysplasias are not
exploited to their full potential in biomedical research.
Since most conditions are rare (< 1:10’000 births) and
correct diagnosis is difficult, only a few medical centres
worldwide have expertise in diagnosis and management
of these disorders. On the other hand, the identification
of many skeletal dysplasia genes and subsequent studies
of their functions and interactions have led to an explo-
sion of knowledge about bone and cartilage biology. The
biomedical literature now contains a large amount of
information about individual genes and gene interac-
tions [1], but it is often difficult to grasp how these
interactions work together in a broader context, such as
at the growth plate. In turn, the focus on specific cases
or genes makes it difficult to identify etiological relation-
ships between skeletal dysplasias, or to recognise clinical
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defects associated with specific molecular pathways.
The International Skeletal Dysplasia Society http://
www.isds.ch/ has attempted to address some of these
problems with its Nosology of Genetic Skeletal Disor-
ders. Since 1972, the ISDS Nosology lists all recognised
skeletal dysplasias and groups them by common clini-
cal-radiographic characteristics and/or molecular disease
mechanisms. The ISDS Nosology is revised every 4
years by an expert committee and the updated version
is published in a medical journal. The latest version is
from 2010 and is presented in [2]. The ISDS Nosology
is widely accepted as the “official” nomenclature for ske-
letal dysplasias within the biomedical community.
While the content of the Nosology is invaluable, the
format of the Nosology has several shortcomings. Firstly,
the classification scheme is inflexible, each disorder is
listed in one group, based either on its clinical radio-
graphic appearance or on its underlying molecular
genetic mechanism (many disorders can be associated
with multiple groups). Secondly, very limited informa-
tion is listed for each entry. Current information is lim-
ited to: the OMIM [3] number, the chromosome locus,
gene name and protein name. In other words, the
Nosology is not linked to freely available and widely
used online repositories such as UniProt [4], limiting
users’ ability to further study the disorders. Thirdly, the
Nosology associates diseases with specific genes but pro-
vides no additional information on the responsible gene
mutations. Fourthly, phenotypic and clinical-radio-
graphic information is present intrinsically in the classi-
fication, but not explicitly in the Nosology. Finally, due
to its current publishing process, the content quickly
becomes outdated, as genes or disorders discovered
after the publication date cannot be included until the
next revision (4 years later). For example, shortly after
the publication of the newest version of the ISDS Nosol-
ogy, Gray et al. [5] have shown that the Serpentine
fibula polycystic kidney syndrome (SFPKS) is charac-
terised by truncating mutations in NOTCH2, and conse-
q u e n t l yh a v ep r o p o s e dt h em o v eo fS F P K Sf r o mt h e
Filamin Group to the Osteolysis Group, due to its
genetic similarities with the Hajdu-Cheney syndrome.
Unfortunately, this information will be reflected in the
Nosology only in four years time.
Over the past 10 years, ontologies have proven to
represent a practical solution to data integration and
knowledge acquisition, processing and management,
particularly in the Healthcare and Life Sciences [6].
Their use in automated annotation [7,8] or cross-linking
for query and retrieval purposes [9,10] is now broadly
recognised in the biomedical field. As a result of their
wide adoption and in order to enable collaboration and
cross-fertilisation, several ontology repositories and
collections have been created. The Open Biomedical
Ontologies Foundry http://www.obofoundry.org/[11]
represents the most prominent collaborative collection
of biomedical ontologies, while the NCBO BioPortal
http://bioportal.bioontology.org/[12] is currently the
most comprehensive ontology repository in this domain.
Ontologies hosted in or linked from these two access
points vary widely in size (ranging from several hun-
dreds to hundreds of thousands of concepts) and
domain (from imaging methods to cell behaviour or
clinical terminology). While an extensive number of bio-
medical topics have been covered, there remain topics
where more comprehensive documentation is required.
One such topic is the skeletal dysplasia domain.
The Bone Dysplasia Ontology aims to complement the
spectrum of existing ontologies and address the specific
knowledge representation shortcomings of the ISDS
Nosology. Its main role is to provide the scaffolding
required for a comprehensive, accurate and formal
representation of the genotypes and phenotypes involved
in skeletal dysplasias, together with their specific and
disease-oriented constraints. As opposed to the current
ISDS Nosology, the ontology enables a shared concep-
tual model, formalised in a machine-understandable
description, in addition to a continuous evolution and a
foundational building block for facilitating knowledge
extraction and reasoning. The symbiosis between the
ontology and the community-driven knowledge curation
platform built to support its evolution enables collabora-
tive and incremental acquisition and encoding of
advances by the experts in the field. Ultimately, it
underpins mechanisms for sharing and re-use of data
and information and advanced reasoning techniques for
semi-automated diagnosis or disease features extraction.
Methods
The Bone Dysplasia Ontology has been built collabora-
tively by a team of experts in skeletal dysplasias and
ontology engineering. The design of the ontology was
heavily influenced by the need to address the limitations
of the ISDS Nosology, or more concretely, the need to
capture the wealth of intrinsic knowledge of the domain
described in diverse case studies or publications. Hence,
the main purpose of the ontology coincides with its
implicit role of providing a shared conceptualisation of
the domain, and is not necessarily dependent on specific
use cases. The community-driven knowledge curation
platform built to support the ontology (described later
in the article) enables a knowledge engineering cycle
that combines a sustainable ontology evolution and
quality-oriented process (enforced by the editorial roles
embraced by the experts in the community) with the
direct use of the ontology for semantic annotation of
clinical summaries and collaborative decision-making.
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knowledge in the skeletal dysplasia domain by providing
a formal foundation to be used by the community to
continuously update the classification of the disease
concepts, thus improving to the current publishing cycle
practice. A second, yet equally important goal, is to
bridge the phenotype and genotype information charac-
terising the diseases, in order to build a comprehensive
body of knowledge from the existing and emerging
patient reports. Consequently, the three important pil-
lars of the domain, as depicted in Figure 1, have been
mapped to the top level classes of the ontology, i.e.,
Bone Dysplasia, Gene Mutation, Gene and Phenoty-
pic Composite. The phenotype information is also cap-
tured by adopting concepts from external ontologies.
In order to avoid ambiguous interpretation and to
enable compatibility between Bone Dysplasia Ontology
concepts and concepts from other ontologies, the top
level classes are rooted in entities defined by the Basic
Formal Ontology (BFO, http://www.ifomis.org/bfo[13],
and where possible by the Ontology of General Medical
Science (OGMS) [14]–a middle ontology rooted in BFO,
which provides a specific framework for medicine, to be
extended by specialised ontologies. The concept map-
pings are listed in the following: (i) Bone Dysplasia
represents a ogms:OGMS_0000047 (Genetic disorder),
(ii) Gene is a snap:MaterialEntity; (iii) Gene Mutation
represents snap:SpecificallyDependentContinuant(s)
as every gene mutation is specific to a particular gene;
(iv) Phenotypic Composite represents a ogms:
OGMS_0000023 (Phenotype).
The Bone Dysplasia, Gene and Protein terms were
manually extracted from the 2010 Revision of the ISDS
Nosology [2]. Gene classes were also augmented with
references to external resources, such as MeSH http://
www.nlm.nih.gov/mesh/, OMIM or Uniprot. Gene
Mutation descriptions were designed according to the
Mutation Nomenclature of the Human Genome Varia-
tion Society [15], to capture the offset of the mutation
and the original and mutated content. For example,
GLY380ARG, 1138 G-A has a NCI: Missense Muta-
tion type attached, an offset of 1138, count 1, original
content G and mutated content A.
In recent years, phenotype ontologies have been seen
as an invaluable source of information, which can enrich
and advance evolutionary and genetic databases [16].
One of the pioneering example, and currently the most
comprehensive source of such information is the
Human Phenotype Ontology (HP) [17]. We imported
concepts from HP to augment the intrinsic skeletal dys-
plasia genetic information with phenotypic descriptions.
However, as noted by [18], most of the terms in HP
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Figure 1 The Bone Dysplasia Ontology. Generic overview of the Bone Dysplasia ontology structure. The high level boxes represent the three
pillars of the domain, i.e., bone dysplasias, phenotype and genotype information. The dotted boxes in the Phenotype information pillar denote
relationships-based dependencies on particular concepts from those ontologies and not subsumption.
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example, Mitral valve prolapse (HP:HP_0001634)c a n
be decomposed into the anatomical entity Mitral valve
and the quality prolapsed. As a result, in order to cap-
ture information currently not covered by HP, but by
also taking into account the aforementioned distinction,
our top level concept Phenotypic Composite enables
the composition of an Anatomical entity,c o n c e p t
imported from the Foundational Model of Anatomy
Ontology [19] or an Anatomical Composite,c o n c e p t
we introduce to model partonomies of anatomical enti-
ties, and a Physical Object Quality, concept imported
the Phenotype and Trait Ontology (PATO) [18] or a
Quality Composite, a concept we define to capture
conjunctions of qualities and qualifiers (e.g., mildly
bowed). The complete structure of the Phenotypic
Composite c a nb es e e ni nF i g u r e2 .Q u a l i t i e sm a ya l s o
have measurement units attached via concepts imported
from Units of Measurement ontology (UO, http://purl.
org/obo/owl/UO). Finally, additional phenotypic infor-
mation, with an accent on clinical radiographic features,
has been foreseen via the import of the Abnormality
concept of the Dynamic Radiological Electronic Atlas of
Malformation Syndromes ontology (dREAMS, http://d-
reams.org/?page_id=84).
The current import of all external concepts followed
the minimum information to reference an external
ontology term (MIREOT) guidelines [20]. The platform
sustaining the evolution of the ontology will ensure that
the import of any additional external concepts will
respect the same guidelines.
The structure of the ontology is a directed acyclic
graph (DAG) based on taxonomical relations and using
the rdfs:subClassOf construct. All classes have fully qua-
lified URIs, while the human-readable description is pro-
vided via the rdfs:label property. Alternative definitions
(e.g., synonyms or acronyms), in addition to references
to external entities are defined by existing or custom
OWL annotation properties, such as skos:altLabel, chro-
mosomal_locus, uniprot_id, omim_no or mesh_id.T h e
metadata describing the ontology is represented using
the DublinCore vocabulary http://purl.org/dc/terms/ and
its defined properties: dc:title, dc:creator, dc:contributor-
and dc:publisher.
We have formalised the ontology using OWL-DL [21],
one of the three sub-languages of the Web Ontology
Language (OWL) because it provides a maximum
expressiveness without losing computational complete-
ness. OWL-DL defines constructs that enable: (i) boo-
lean combinations of class expressions (such as union or
intersection, required to integrate diverse vocabularies
for describing the phenotype information); (ii) as well as
disjointness and equivalence class axioms; and (iii) arbi-
trary cardinality restrictions. Furthermore, the sublan-
guage has also developed a wide range of mature
reasoners, which makes it an ideal candidate for real-
world practical applications.
From a pragmatical perspective, we opted for using a
logical formalism, because only a well-structured, logical
representation framework is able to encode the relations
existing between phenotypic and genotypic characteris-
tics in the context of particular bone dysplasias. The
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Figure 2 Connecting the bone dysplasias to phenotype information. Dotted circles represent concepts from external ontologies. The
direction of the arrows have the same meaning as in Figure 3.
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ceptual real-world knowledge of the domain (e.g.,
Achondoplasia is characterized by a mutation in gene
FGFR3 and by Hydrocephalus or Lumbar hyperlordo-
sis), but also enable us to use this conceptual knowledge
to perform reasoning on patient instance data.
The Bone Dysplasia Ontology was curated manually
using the Stanford Protege-OWL 4.1 http://protege.stan-
ford.edu/ ontology editor. For reasoning purposes, the
ontology imports (via owl:imports statements) the
Human Phenotype Ontology and the Phenotype and
Trait Ontology, but also specific concepts from different
other ontologies, as specified above and further
described in the following section. The consistency
checking has been performed by running the OWL-DL
Pellet v2.1.2 [22] and Hermit v1.3.3 [23] reasoners over
the ontology, to analyse both the class and object prop-
erty definitions.
Results and discussion
This section details the classes defined by the Bone Dys-
plasia Ontology and the class axioms and relations that
we have introduced in order to accurately model the
existing knowledge in the domain. It also discusses the
availability of the ontology and our envisioned revision
and extension cycle.
The Bone Dysplasia Ontology classes
T h es t r u c t u r eo ft h eo n t o l o g yi sc o n c e p t u a l l yb u i l t
around three main knowledge pillars: bone dysplasias,
genotype information and phenotype information, as
depicted in Figure 1. The ontology consists of 1228
own-defined classes, of which 515 define bone dyspla-
sias, 254 define genes, 361 define gene mutations and
224 define proteins.
The skeletal dysplasias component comprises the hier-
archy of diseases, starting from the Bone Dysplasia
super-concept which is refined via taxonomical relations
(i.e., rdfs:subClassOf) to 40 specific groups of diseases
(e.g., rotect Acromelic Dysplasias, Aggrecan Group or
Patellar dysostoses) and then to dysplasias defined
within the groups. Figure 4 presents a small portion of
the classification. In principle, the hierarchy has two
levels, i.e., the group level and the leaf level representing
bone dysplasias, however, there are also cases where the
depth of the hierarchy is three. Such an example exists
in the Craniosynostosis syndromes group, where the
class Pfeiffer syndrome FGFR2-related has two sub-
classes Antley-Bixler variants caused by FGFR2 muta-
tions and Jackson-Weiss syndrome. In principle, all
classes defined at this level, such as the aforementioned
two, represent diseases maintained only for historical
purposes. The Nosology mentions them as being sub-
s u m e db ys o m eo t h e rd i s o r d e r s( v i as i m p l e
observations), like the Pfeiffer syndrome FGFR2-
related in our example, and hence we added them as
subclasses of the corresponding concepts in the
hierarchy.
Similar or equivalent bone dysplasia concepts, includ-
ing a HP_0002652 (Skeletal dysplasia) super-concept,
are also defined by the Human Phenotype Ontology.
However, a correct alignment between these terms and
the terms defined within our ontology, both from the
domain and the logical perspectives, cannot be realised
due to either the vagueness or the improper granularity
of the concepts. For example, HP defines concepts such
as HP_0005716 (Lethal skeletaldysplasia)o r
HP_0005685 (Severe skeletal dysplasia), which seem to
be rather qualities than proper disease definitions. Simi-
larly, concepts like HP_0002654 (Multiple epiphyseal
dysplasia), are defined in our ontology at a much more
fine-grained level via several concepts, e.g., in this case
via seven classes (see Multiple epiphyseal dysplasia
and pseudoachondroplasia Group).
The genotype information pillar captures Gene Muta-
tion(s) and their associated Gene(s) and Proteins (see
Figure 3). Each of these concepts have a corresponding
class in the ontology and subsume particular sub-con-
cepts. Gene Mutation classes are related to Gene
classes via the has_locus relation. Similarly, Protein
classes are related to Gene classes via the is_encoded_by
relation. The naming of the subclasses of these three
concepts follows an incrementally encoded structure,
e.g., GM0000001 for a gene mutation, G0000001 for a
gene, and P0000001 for a protein. However, genes and
proteinsalso have human readable names provided via
the rdfs:label property and synonyms via the skos:altLa-
bel property. For example, G0000047 has the label
MNX1 and the alternative label (or synonym) HLXB9.
Gene mutations are defined according to the Mutation
Nomenclature of the Human Genome Variation Society
[15], to capture the offset of the mutation, along with
the original and mutated content, via four datatype
properties: original_content, offset, count and mutated_-
content. The type of the mutation is signalled by the
mutation_type relation between Gene Mutation and
NCI:Mutation Abnormality, the latter concept being
imported in our ontology together with its entire sub-
structure (see below for a gene mutation example).
Gene concepts are linked to multiple external resources,
e.g., OMIM, Uniprot or MeSH via corresponding anno-
tation properties: omim_no, uniprot_id, mesh_id, umls_-
cui, ref_seq, entrezgene_id and accesion_no.
A sas i d er e m a r k ,t h eo n t o l o g yc o n t a i n sas e c o n d
Gene Mutation class, imported from the NCI thesaurus
as part of the NCI:Mutation Abnormality sub-tree.
The BDO and the NCI Gene Mutation classes are not
equivalent. The BDO Gene Mutation is an entity that
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having a type, encoding, offset, etc.). The NCI Gene
Mutation is, in reality, improperly defined because it
refers to a type of mutation and not to a gene mutation
per se. This can be easily observed by analysing the con-
cepts imported from NCI under the NCI:Mutation
Abnormality super-concept, which describe different
types of gene mutations. However, since we rely on
these mutation type concepts and import them accord-
ing to the MIREOT principle, we were not able to omit
this particular concept, and hence to avoid confusion.
The phenotype information (depicted in Figure 2) is
r e c o r d e di nah i g h l ye x t e n s i b l em a n n e rv i at h em a i n
class Phenotypic Composite. The complex nature of
skeletal dysplasias can be observed in particular in the
wide range of clinical and radiographic characteristics
manifested by patients. Consequently, we opted for re-
using concepts from known ontologies that subsume
most of the possibly arising phenotype information in
patient records, e.g., REAMS:Abnormality for radio-
graphic features and HP:HP_0000118 (Phenotypic
abnormality) for other phenotypic findings. As discussed
earlier, our Phenotypic Composite class represents a
composite element that connects conceptually an otect
FMA:Anatomical entity or an Anatomical Composite
to a PATO:Physical Object Quality or a Quality Com-
posite using the describes and has_quality relations, or
can build upon existing composites via the OBO has_-
part relation in addition to connecting a PATO:
Physical Object Quality or a Quality Composite via
the has_quality relation. The FMA:Anatomical entity
and PATO:Physical Object Quality concepts have been
imported in our ontology, however, choosing particular
sub-concepts and specialising their relations to particu-
lar dysplasias is deferred to the community and sup-
ported by the platform described later in the paper.
Hence, Phenotypic Composite carries a scaffolding role
onto which particular elements can be created to com-
plement the gaps in the current phenotype ontologies.
Some definition examples are, however, presented both
in the ontology, as well as in the following section.
Class axioms and relationships
Table 1 lists the main relations introduced by the Bone
Dysplasia Ontology. The mode_of_inheritance relation-
ship links Bone Dysplasia(s) to diverse modes of inheri-
tance from the Human Phenotype Ontology (via
HP_0000005). The mutation_type relation provides a
connection between Gene Mutation and the NCI:
Mutation Abnormality that defines all possible gene
mutation types, while the has_locus relation links Gene
Mutation to a Gene.F i n a l l y ,t h echaracterized_by rela-
tion provides support for associating Bone Dysplasia(s)
to Phenotypic Composite(s), Gene Mutation(s) or HP:
HP_0000118 (Phenotypic Abnormality). To these are
added the two relations mentioned above, i.e., describes
and has_quality,a n dt h ehas_anatomical_coordinate
relation, used to connect a Anatomical Composite to a
Gene
Mutation
Gene Protein
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Mutation
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has_locus
is_encoded_by
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chromosomal_locus
omim_no
mesh_id
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Figure 3 Connecting the bone dysplasias to genotype information. Dotted circles represent concepts from external ontologies. The dotted
box represents annotation properties attached to the Gene concept. The direction of the arrows shows domain-range association in the
property definition.
Groza et al. BMC Bioinformatics 2012, 13:50
http://www.biomedcentral.com/1471-2105/13/50
Page 6 of 13Bone 
Dysplasia
Acromelic
Dysplasias
Aggrecan
Group
Filamin
Group
Patellar
dysostoses
...
...
Acrodysostosis
Acromicric
dysplasia
Atelosteogenesis
type 1
Atelosteogenesis
type3
Ischipatellar
dysplasia
Nail-patella
syndrome
Figure 4 Bone Dysplasias classification. The main Bone Dysplasia concept is connected to lower level concepts via rdfs:subClassOf relations.
Table 1 Relations defined in the Bone Dysplasia ontology
Relation Domain Range
characterized_by Bone Dysplasia Phenotypic Composite, Gene Mutation
HP:HP_0000118 (Phenotypic abnormality)
mode_of_inheritance Bone Dysplasia HP: HP_0000005 (Mode of inheritance)
has_locus Gene Mutation Gene
mutation_type Gene Mutation NCI:Mutation Abnormality
is_encoded_by Protein Gene
describes Phenotypic Composite Anatomical Composite, FMA:Anatomical_Entity
has_quality Phenotypic Composite Quality Composite,
PATO:PATO_0001241(Physical object quality)
has_qualifier Quality Composite PATO:PATO_0000068(Qualitative),
PATO:PATO_0001241(Physical object quality)
has_anatomical_coordinate Anatomical Composite FMA:Primary_anatomical_coordinate,
FMA:Secondary_anatomical_coordinate
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ary anatomical coordinate,a n dt h ehas_qualifier rela-
tion that enables the attachment of qualifiers from
PATO:PATO_0000068 (Qualitative)a n dprotect
PATO:PATO_0001241 (Physical object quality)t o
Quality Composite(s).
A major aim of the Bone Dysplasia ontology is to
underpin a community-driven knowledge curation plat-
form that enables collaborative decision making and
knowledge exchange among the experts in the field. In
order to support the decision making process (i.e., colla-
borative diagnosis), as well as the transfer of knowledge
from particular patient studies to the generic concept
definitions, we encoded the semantics of the emerging
knowledge discoveries in class axioms and restrictions.
Furthermore, to reflect the current domain knowledge
about each specific dysplasia accurately, these class
axioms are specialised at the lower levels of the Bone
Dysplasia concept with more specific details. As a result,
more than 70% of actual bone dysplasia concepts are
linked to gene mutations, and around 80% of the same
concepts have phenotype information attached (via more
than 2,000 phenotypes imported from the Human Phe-
notype Ontology). The lack of class axioms in the rest of
the bone dysplasia concepts is due, in principle, to two
factors. From the genetic perspective, the corresponding
bone dysplasias currently have no established links with
particular genes, while from the phenotype perspective,
we were, until now, unable to mine disorder–phenotype
relations for the corresponding bone dysplasias.
The class definition of three of the top-level concepts
(as Gene is an independent material entity) are pre-
sented below, using the OWL Manchester syntax:
Class: Bone_Dysplasia
SubClassOf:
OGMS:OGMS_0000047
SubClassOf:
characterized_by only (REAMS:Abnorm-
ality or HP:HP_0000118
or Phenotypic_Composite or Gene_
Mutation)
SubClassOf:
mode_of_inheritance only HP:
HP_0000005
Annotations:
skos:description “A genetic disorder
that involves abnormal
development of bones and connective
tissues.”
Definition: Bone_Dysplasia is defined as a specialisa-
tion is defined as a specialisation has two restrictions: (i)
all concepts that characterise this entity (via
characterized_by) are Gene_Mutationso rPhenotypic_-
Composites, or REAMS:Abnormality or HP:
HP_0000118 (Phenotypic abnormality), and (ii) all con-
cepts providing a mode_of_inheritance for this entity are
HP:HP_0000005 (Mode of inheritance).
Class: Gene_Mutation
SubClassOf:
SNAP:
SpecificallyDependentContinuant
SubClassOf:
has_locus only Gene and has_locus
some Gene
SubClassOf:
mutation_type only NCI:Mutation_
Abnormality
and mutation_type some NCI:Mutation_
Abnormality
Annotations:
skos:description “A change or altera-
tion in a gene.”
Definition: Gene_Mutation is defined as a specialisa-
tion of an entity that has two restrictions: (i) all con-
cepts acting as a locus for this entity (via has_locus)a r e
Genesa n dt h e r ei sa tl e a s to n es u c hGene that is the
locus of this entity, and (ii) all concepts that define the
mutation_type for this entity are NCI:Mutation_Ab-
normality and there is at least one such NCI:Mutatio-
n_Abnormality that provides a mutation type.
Class: Phenotypic_Composite
SubClassOf:
OGMS:OGMS_0000023
SubClassOf:
(has_part some Phenotypic_Composite
and has_part only Phenotypic_
Composite)
or
(describes some FMA:Anatomical_
entity
and describes only FMA:Anatomical_
entity)
or
(describes some Anatomical_composite
and describes only Anatomical_
composite)
SubClassOf:
(has_quality only PATO_0001241
and has_quality some PATO_0001241)
or
(has_quality only Quality_Composite
and has_quality some Quality_
Composite)
Groza et al. BMC Bioinformatics 2012, 13:50
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skos:description “A continuant
describing the conjunction
between a quality and an anatomical
part or an anatomical
composite.”
Definition: Phenotypic_Composite is defined as a spe-
cialisation of an entity that has two restrictions: (i) the
entity either has_part some concepts that are all Phenoty-
pic_Composite and there exist at least one such Phenoty-
pic_Composite that is a part of the entity, or all concepts
described by this entity (via describes) are FMA:Anatomi-
cal_entity and there is at least one such FMA:Anatomi-
cal_entity that is described by the entity, or all concepts
d e s c r i b e db yt h i se n t i t y( v i adescribes)a r eAnatomical_-
Composite and there is at least one such Anatomical_-
Composite that is described by the entity, and (ii) all
concepts that define a quality for this entity (via has_qual-
ity)a r ePATO:PATO_0001241 and there is at least one
such PATO:PATO_0001241 that provides a quality, or
all concepts that define a quality forthis entity (via has_qu-
ality)a r eQuality_Composite and there is at least one
such Quality_Composite that provides a quality.
Below, we illustrate a series of concrete concept defi-
nition examples, for the Achondroplasia and
GM0000001 classes and two particular Phenotypic
Composites–Translucency of proximal femur and Oval
translucency of proximal femur, by showing the some of
the definition constraints, and in the case of the gene
mutation, the information captures along the lines of
the Mutation Nomenclature of the Human Genome
Variation Society:
Class: Achondroplasia
SubClassOf:
characterized_by only (GM000001 or
GM000361
or HP_0000238 or HP_0002938 or
HP_0002968 or HP_0003505 or ...)
SubClassOf:
mode_of_inheritance only HP_0000006
and
mode_of_inheritance some HP_0000006
Class: GM000001
SubClassOf:
has_locus only G0000001 and has_locus
some G0000001
SubClassOf:
mutation_type only NCI:Missense_Mu-
tation and
mutation_type some NCI:Missense_
Mutation
Annotations:
encoding “GLY380ARG, 1138 G-A”, off-
set 1138,
original_content “G”, mutated_con-
tent “A”
Class: PC_0000004
SubClassOf:
describes only AC_0000001 and
describes some AC_0000001
SubClassOf:
has_quality only PATO:PATO_0001354
and1
has_quality some PATO:PATO_0001354
Annotations:
label “Translucency of proximal
femur”
skos:description “Translucent proxi-
mal area of femur”
Class: AC_0000001
SubClassOf:
has_part only FMA:Femur and has_part
some FMA:Femur
SubClassOf:
has_anatomical_coordinate only FMA:
Proximal and
has_anatomical_coordinate some FMA:
Proximal
Annotations:
label “Proximal femur”
skos:description “The proximal area
of the femur”
Class: PC_0000005
SubClassOf:
describes only AC_0000001 and
describes some AC_0000001
SubClassOf:
has_quality only QC_0000001 and has_
quality some QC_0000001
Annotations:
label “Oval translucency of proximal
femur”
skos:description “Oval-shaped trans-
lucent area of the proximal femur”
Class: QC_0000001
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has_part only PATO:PATO_0001354 and
has_part some PATO:PATO_0001354
SubClassOf:
has_qualifier only PATO:PATO_0000947
and
has_qualifier some PATO:PATO_0000947
Annotations:
label “Oval translucency”
skos:description “Oval-shaped area
of translucency”
Availability
Table 2 summarises the main characteristics of the Bone
Dysplasia Ontology. The current release of the ontology
has the version number 1.5, and the namespace of the
ontology is http://purl.org/skeletome/bonedysplasia. The
classification of the bone dysplasias defined in the ontol-
ogy corresponds to the ISDS Nosology 2010 [2], which
has only recently been published. The ontology can be
retrieved directly from the given namespace, or visua-
lised using the NCBO BioPortal at: http://bioportal.
bioontology.org/ontologies/1613.
The design of the ontology aims to re-use and adopt
existing vocabularies in order to minimize the re-inven-
tion, duplication and overlap of concepts. Consequently,
the ontology imports, following the MIREOT guidelines
[20], a series of concepts from external resources, as pre-
viously discussed. Additionally, the Gene concepts
include references to OMIM, Uniprot, MeSH, and UMLS
via corresponding annotation properties, while the Bone
Dysplasia concepts refer to OMIM and MeSH.
Revising and extending the Bone Dysplasia Ontology
The Bone Dysplasia ontology has been built as a foun-
dation block for SKELETOME–the skeletal dysplasia
knowledge curation platform (described in the following
section). As such, support for extensibility is important,
to cope with the complex and evolving nature of the
field. Consequently the SKELETOME platform has been
designed to enable roundtrip knowledge engineering,
which assumes the evolution of the ontology. New dis-
coveries emerging from patient studies will be easily
transferred at the conceptual level by domain experts
(via class axioms) through extensions to the ontology
and through additional semantic inference rules, as well
as at the instance level as new case data becomes avail-
able. In addition to refined class definitions via specia-
lised restrictions, the platform allows users with editorial
roles to alter the bone dysplasia classification, by creat-
ing or deleting groups, or by moving diseases between
groups. This leads to a continuous evolution of the
ontology and inherently of the Nosology and bone dys-
plasia knowledge.
Comparison to related ontological resources
Among the three pillars of the Bone Dysplasia ontology,
the actual skeletal dysplasia knowledge (representing the
core of the ontology) is covered only superficially in
other ontologies and vocabularies. Examples such as the
Systematized Nomenclature of Medicine–Clinical Terms
(SNOMED-CT, http://www.ihtsdo.org) [24], REAMS,
the NCI Thesaurus [25] or the Human Disease Ontol-
ogy include, as also highlighted in the Background sec-
tion, only high level concepts denoting the most
commonly known dysplasias. None of these existing
related vocabularies attempt to capture related genotype
or phenotype information. The added value of the Bone
Dysplasia ontology stands in the comprehensive classifi-
cation of these disorders, in addition to an accurate
descriptions (via class axioms and relations) of their
main genetic and phenotypic characteristics. We regard
the other ontologies, in particular REAMS, SNOMED
and the NCI thesaurus, as effective complements and
important resources to be cross-referenced and re-used
(to avoid redundancy) to describe the phenotype and
genotype information of bone dysplasias.
To date, the integrity of the ontology has been
ensured by the domain experts-driven curation. Future
testing of its applicability will be evidenced by the extent
of its changes over time and the future growth of the
SKELETOME knowledge base and its associated com-
munity of users.
Community-driven knowledge curation
The increasing use of ontologies in Healthcare and Life
Sciences has led to novel ways of processing digital con-
tent, which in turn have introduced new possibilities of
dealing with scientific publications and data [6]. Such
content processing techniques make knowledge more
open and exploitable than ever before [8,26].
Table 2 Bone Dysplasia Ontology fact sheet
Name Bone Dysplasia Ontology
Namespace http://purl.org/skeletome/bonedysplasia
Prefix BDO
Scope skeletal dysplasias, genes, proteins,
gene mutations and phenotypic
characteristics in human
Format OWL-DL
Number of classes 1228
Dependencies (import) HP, PATO, NCI (Gene mutation types)
Dependencies (weak) FMA, REAMS
Annotations rdfs:label, skos:altLabel, uniprot_id
entrezgene_id, ref_seq, mesh_id, locus,
omim_no, umls_cui, accession_no
skos:description
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and evolution of the ontology by transferring knowledge
present in existing and emerging patient case studies
into class axioms or cross-references to external pheno-
type ontology concepts. In order to achieve this, we
developed the SKELETOME platform http://skeletome.
metadata.net/skeletome, a community-driven knowledge
curation platform that enables collaborative input, shar-
ing and re-use of data and information among experts
in the skeletal dysplasia domain. SKELETOME provides
a central access point to a rich skeletal dysplasia knowl-
edge base, supported by low-level features, such as user
and group-based access and privacy control. At the
same time, from a high-level perspective, the anon-
ymised pool of case studies enables statistical inference
for knowledge discovery purposes or computer-assisted
diagnosis.
SKELETOME is built as a Drupal 7 http://drupal.org/
instance, thus inherently providing the collaborative
aspects, and also allowing us to develop custom modules
to suit our needs. The Bone Dysplasia Ontology acts as
the knowledge back-bone of the platform. Each of the
disease concepts present in the hierarchy of skeletal dys-
plasias has been imported, via its own module, into the
platform and has an associated human-readable page.
The system structure is similar to a knowledge Wiki
that is built around the ontology. The user-friendly page
corresponding to each dysplasia, presents a summary of
the dysplasia and contains pointers to external refer-
ences. Registered members of the community can add
facts grounded in scientific publications (similar to the
OMIM structure) and can discuss facts added by other
members. Members with editorial role have the ability
of editing the summary of dysplasias by incorporating
the facts widely accepted by the community. They are
also able to alter the bone dysplasia pages by, for exam-
ple, moving them between groups. Such operations have
a direct impact on the ontology and are immediately
reflected in the underlying knowledge base. The contin-
uous logical correctness of the ontology is always
enforced by the platform, without the experts noticing
it. In practice, we have created a round-trip knowledge
engineering process, driven by the experts in the com-
munity (only a few experts have editorial roles) who are
not required to possess any ontology engineering skills.
The development of the actual knowledge-base about
bone dysplasias is supported by SKELETOME’sk n o w l -
edge engineering cycle. On one side, the BDO concepts
(including also concepts from the imported ontologies)
are used to annotate patient case studies that can be
uploaded, analysed and discussed by the members of the
community. More concretely, the platform enables man-
ual and automatic semantic annotation of clinical sum-
maries (see Figure 5), as well as manual annotation of
X-Ray imagery. In addition to annotation, SKELETOME
uses the ontology to provide support in the collaborative
diagnosis process via an underlying decision support
mechanism, that computes probabilistic correlations of
phenotypes in the context of a particular disorder, or
raked list of disorders given particular phenotypes. The
actual mechanisms perform association rule mining on
existing patient data and refines the resulting rules
Figure 5 Semantic Annotation in SKELETOME. Tagging clinical summaries in SKELETOME using the Bone Dysplasia ontology and references
to external ontologies. The example shows a clinical summary tagged with terms from the Human Phenotype Ontology and subclasses of the
Bone Dysplasia concept.
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ders before computing the final probabilistic rankings.
Overall, the patient information is automatically linked,
via the underlying ontological concepts, to the bone dys-
plasia concepts and pages. On the other side, from the
dysplasias perspective, the ontology creates an integrated
view on the phenotype and genotype emerging from
patient reports and evolves based on the findings pro-
vided by the analysis of patient cases combined with the
current domain knowledge. This is presented to the
user in form of a ontology analytics service for explora-
tory purposes and is realised via direct querying on the
ontology (see Figure 6 for an example).
The SKELETOME platform and knowledge-base,
underpinned by the Bone Dysplasia ontology, represents
an ideal approach by which experts in the skeletal dys-
plasias domain can collaboratively document, expand
and maintain a curated body of the knowledge which
will lead to accelerated innovation and scientific break-
throughs in their field.
Conclusions
The Bone Dysplasia ontology described in this paper,
represents the most comprehensive structured
knowledge source for the skeletal dysplasias domain. It
provides the means for integrating and annotating clini-
cal and research data, not only at the generic domain
knowledge level, but also at the level of individual
patient case studies–by enabling links between indivi-
dual cases and publicly available genotype and pheno-
type resources. The community-driven curation process
ensures a shared conceptualisation of the domain
knowledge and its continuous incremental evolution.
Future development of both the ontology and the SKE-
LETOME platform will focus on advancing the reason-
ing and knowledge extraction services–which will
hopefully lead to the discovery of previously unknown
relationships between gene mutations, phenotype char-
acteristics and bone dysplasias and the discovery of new
drugs to combat disorders associated with human bone
and cartilage development.
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